Pacific Biosciences of California Inc. buy The Goldman Sachs Group, Inc.
Start price
10.04.24
/
50%
€3.26
Target price
10.04.25
€6.50
Performance (%)
-49.83%
Price
02.05.24
€1.64
Summary
This prediction is currently active. Massive losses of -49.83% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 10.04.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacific Biosciences of California Inc. | 27.649% |
iShares Core DAX® | 0.000% |
iShares Nasdaq 100 | 0.626% |
iShares Nikkei 225® | 1.568% |
iShares S&P 500 | 0.334% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.81
30.06.23
30.06.23
€15.60
30.06.24
30.06.24
-87.23%
02.05.24
02.05.24